DRUGS & SUPPLEMENTS
Ezevas usesEzevas consists of Atorvastatin, Ezetimibe.
Ezevas is a lipid-lowering drugs of the statin group. An inhibition of HMG-CoA reductase leads to a series of sequential reactions that result in reduced intracellular cholesterol content and it is a compensatory increase in activity of LDL receptors and thus accelerate the catabolism of LDL cholesterol.
The lipid-lowering effect of statins is associated with lower levels of total cholesterol by LDL-C. The reduction in LDL cholesterol is dose-dependent and is not linear, but exponential. The inhibitory effect of Ezevas (Atorvastatin) on HMG-CoA reductase by about 70% determined by the activity of its circulating metabolites.
Statins do not affect the activity of lipoprotein lipase and hepatic, no significant effect on the synthesis and catabolism of free fatty acids, so their effect on triglycerides and again vicariously through their main effects on reducing LDL-C.
In addition to lipid-lowering actions, statins have beneficial effects in endothelial dysfunction (pre-clinical sign of early atherosclerosis) in the vascular wall, the state of atheroma, improves blood rheology, have antioxidant, antiproliferative properties.
Ezevas (Atorvastatin) lowers cholesterol levels in patients with homozygous familial hypercholesterolemia, which is usually not amenable to therapy with lipid-lowering agents.
Ezevas (Atorvastatin) is rapidly absorbed from the gastrointestinal tract. The absolute bioavailability is low (about 12%) due to first-pass clearance in gastrointestinal mucosa and / or due to the "first pass" through the liver, predominantly in the scene. Ezevas (Atorvastatin) is metabolized with the participation of isoenzyme CYP3A4 to form a number of substances which are inhibitors of HMG-CoA reductase inhibitors.
T1/2 from plasma is about 14 hours, although the T1/2 inhibitor activity of HMG-CoA reductase is approximately 20-30 hours, due to the involvement of active metabolites.
The plasma protein binding is 98%.
Ezevas (Atorvastatin) is excreted in the form of metabolites mainly in the bile.
Why is Ezevas prescribed?
Primary hypercholesterolemia in ineffectiveness of diet, combined hypercholesterolemia and hypertriglyceridemia, heterozygous and homozygous familial hypercholesterolemia with the ineffectiveness of diet.
Dosage and administration
The treatment by Ezevas is with a standard diet for patients with hypercholesterolemia. The dose is determined individually, depending on the initial cholesterol levels. This medication is taken orally. The initial dose is usually 10 mg 1 time / day. The effect is manifested within 2 weeks, and the maximum effect is for 4 weeks. If necessary, the dose can be gradually increased every 4 weeks or more. The maximum daily dose is 80 mg.
Ezevas (Atorvastatin) side effects, adverse reactions
Digestive system: constipation, flatulence, dyspepsia, abdominal pain, nausea, diarrhea.
CNS and peripheral nervous system: headache, insomnia.
Other: asthenia, myalgia.
Liver disease in the active phase, increasing the serum transaminase activity more than 3 times of unknown origin, pregnancy, lactation (breastfeeding), hypersensitivity to Ezevas (Atorvastatin). Women of reproductive age not using reliable contraception.
Using during pregnancy and breastfeeding
Ezevas is contraindicated during pregnancy and lactation (breastfeeding).
It is not known whether Ezevas (Atorvastatin) is allocated in breast milk. Given the potential for adverse effects in infants, if necessary to use this drug during lactation it should decide on the termination of breastfeeding.
Women of reproductive age during treatment should use adequate contraceptive methods. Ezevas (Atorvastatin) may be used in women of childbearing age only if the probability of pregnancy is very low, and the patient informed about the possible risk of treatment for the fetus.
Category of the fetus by FDA - X.
Prior to and during treatment with Ezevas (Atorvastatin), especially if symptoms of liver damage, it is necessary to monitor liver function tests. With an increase in transaminase levels it should be monitored their activity up to normalization. If AST or ALT more than 3 times the norm persists, we recommend reducing the dose or withdrawal of Ezevas (Atorvastatin).
When prompted during the treatment of symptoms of myopathy it should determine the activity of creatine kinase. If a significant increase in CK levels is preserved, it is recommended to reduce the dose of Ezevas (Atorvastatin) or to cancel taking it.
The risk of myopathy during the treatment with Ezevas (Atorvastatin) increased, while the use of cyclosporine, fibrates, erythromycin, antifungal agents belonging to azoles, and niacin.
There is a likelihood of the following side effects, but not in all cases, a clear link with taking Ezevas (Atorvastatin): muscle cramps, myositis, myopathy, paresthesia, peripheral neuropathy, pancreatitis, hepatitis, cholestatic jaundice, anorexia, vomiting, alopecia, pruritus, rash, impotence, hyperglycemia and hypoglycemia.
The children experience of Ezevas (Atorvastatin) using at a dose of 80 mg / day is restricted.
With careful use Ezevas (Atorvastatin) in patients with chronic alcoholism.
Ezevas drug interactions
When this drug applied simultaneously with:
- digoxin slightly increased concentration of digoxin in plasma.
- itraconazole greatly increases the concentration of Ezevas (Atorvastatin) in plasma, apparently due to inhibition of itraconazole its metabolism in the liver that occurs with the participation of isoenzyme CYP3A4; increased risk of myopathy.
- colestipol may decrease the concentration of Ezevas (Atorvastatin) in plasma, with lipid-lowering effect is enhanced.
- antacids containing magnesium hydroxide and aluminum hydroxide, reduce the concentration of Ezevas (Atorvastatin) by approximately 35%.
- cyclosporine, fibrates (including gemfibrozil), azole antifungals derivatives, nicotinic acid increases the risk of myopathy.
- erythromycin, clarithromycin moderately increased concentrations of Ezevas (Atorvastatin) in plasma, increases the risk of myopathy.
- ethinyl estradiol, norethisterone (norethindrone) slightly increases the concentration of ethinyl estradiol, norethisterone and (norethindrone) in blood plasma.
- protease inhibitors increases the concentration of Ezevas (Atorvastatin) in plasma, as protease inhibitors are inhibitors of the CYP3A4 isoenzyme.
Diltiazem, verapamil, isradipine inhibit isoenzyme CYP3A4, which participates in the metabolism of Ezevas (Atorvastatin) Sanis Health, so that while the use of these calcium channel blockers may increase the concentration of Ezevas (Atorvastatin) in plasma and increased risk of myopathy.
Ezevas in case of emergency / overdose
Treatment: symptomatic and supportive therapy. There is no specific antidote. Hemodialysis is ineffective.
Ezevas Dr. Lazar Laboratorio information
Ezevas (Ezetimibe) Dr. Lazar Laboratorio belongs to antihyperlipidemic category of drugs. Ezevas (Ezetimibe) Dr. Lazar Laboratorio is best effective in lowering the amount of absorbable amount of cholesterol in body. This drug amazingly reduces the amount of total cholesterol and LDL (bad) cholesterol. The power of Ezevas (Ezetimibe) Dr. Lazar Laboratorio doesn't stop here. It also reduces the amount of apolipoprotein B protein that creates cholesterol in the blood. Ezevas (Ezetimibe) Dr. Lazar Laboratorio is the physician's first choice in bringing down cholesterol and tri-glyceride level in blood. Often, prescribed to be taken with low cholesterol diet and complementary lipid reducing drugs, Ezevas (Ezetimibe) Dr. Lazar Laboratorio is capable of stopping physical problems due to blocked blood vessels. Apart from this, Ezevas (Ezetimibe) Dr. Lazar Laboratorio is often used by doctors for treating other diseases. Ezevas (Ezetimibe) Dr. Lazar Laboratorio cuts short all the life threatening risk factors caused due to higher cholesterol levels in blood. Patients suffering from cholesterol related problems may find this drug to be very effective and useful if taken regularly.
Ezevas Dr. Lazar Laboratorio warnings
Inform your doctor before taking Ezevas (Ezetimibe) Dr. Lazar Laboratorio if you have liver disease or any kind of muscle pain or weakness. It is also safer to let the doctor know if you are taking any other such cholesterol reducing drug or restricted diet. Ezevas (Ezetimibe) Dr. Lazar Laboratorio may not work to the fullest if you are suffering from overweight. Although it has not been tested on pregnant women, it has shown birth defects when tested on animal.
There is still doubt as to whether Ezevas (Ezetimibe) Dr. Lazar Laboratorio passes into breast milk or not. But it is apprehended that it may cause serious disorders in nursing babies. So it is always recommended to consult your doctor if you are pregnant or breast-feeding before taking this drug. Children under the age of 10 should not be put on this drug. Ezevas (Ezetimibe) Dr. Lazar Laboratorio is not yet tested on older patients and is also not expected to create harmful effects in them.
Ezevas (Ezetimibe) Dr. Lazar Laboratorio may not work in harmony with other drugs. Let your physician know if you are taking any of the following drugs:
Cholesterol-reducing drugs like such as gemfibrozil
Ezevas Dr. Lazar Laboratorio side effects
Intake of Ezevas (Ezetimibe) Dr. Lazar Laboratorio is followed by a host of side effects. Stop taking this drug instantly if you experience breathing trouble, closed throat, swollen lips, tongue, or face and take required medical aid from your doctor.
Side effects like high body temperature, headache, muscle pain, running nose, sore throat, body ache, chest pain, congestion, cough, diarrhea, difficulty in moving, drowsiness, stomach pain, soft and swollen glands in neck, tightness of chest, difficulty in swallowing, fatigue and voice changes are very common and less harmful.
Amongst the less found side effects of Ezevas (Ezetimibe) Dr. Lazar Laboratorio, huge swelling of face, eyelids, lips, tongue, throat, hands, legs, feet, sex organs, skin rash etc. are notable. Always seek a doctor's help if any of these side effects appears.
Ezevas Dr. Lazar Laboratorio overdose
Ezevas (Ezetimibe) Dr. Lazar Laboratorio works wonder only when taken regularly and properly. Overdose of Ezevas (Ezetimibe) Dr. Lazar Laboratorio is not recommended and can be harmful. Symptoms of overdose are, however, not known. Nevertheless, rush to a doctor as soon as you feel that you have taken in a double dose.
Missing a dose of Ezevas (Ezetimibe) Dr. Lazar Laboratorio may not be that harmful. Take the missed dose as soon as you remember. But if it is almost time for the next dose, skip the missed one and go for the scheduled one. time for the next dose, skip the missed dose and take only the next regularly scheduled dose. Do not take a double dose of the medication.
Ezevas Dr. Lazar Laboratorio Usage Guidelines
Your physician is the best person to provide you with the right usage guidelines. Regularity and punctuality are the keywords. Generally, it can be said that, Ezevas (Ezetimibe) Dr. Lazar Laboratorio is taken with a full glass of water, once a day with or without food. If you are on bile acid sequestrant such as Cholestyramine (Locholest, Prevalite, Questran), colestipol (Colestid), or colesevelam (Welchol), take Ezevas (Ezetimibe) Dr. Lazar Laboratorio 2 hours before or 4 hours after taking the acid sequestrant. While you are on Ezevas (Ezetimibe) Dr. Lazar Laboratorio mediaction, take food low on cholesterol. Do not ignore taking medical tests if your doctor asks for. Also dont stop taking Ezevas (Ezetimibe) Dr. Lazar Laboratorio without your doctor's approval.
Ezevas pharmaceutical active ingredients containing related brand and generic drugs:
Active ingredient is the part of the drug or medicine which is biologically active. This portion of the drug is responsible for the main action of the drug which is intended to cure or reduce the symptom or disease. The other portions of the drug which are inactive are called excipients; there role is to act as vehicle or binder. In contrast to active ingredient, the inactive ingredient's role is not significant in the cure or treatment of the disease. There can be one or more active ingredients in a drug.
Ezevas available forms, composition, doses:
Form of the medicine is the form in which the medicine is marketed in the market, for example, a medicine X can be in the form of capsule or the form of chewable tablet or the form of tablet. Sometimes same medicine can be available as injection form. Each medicine cannot be in all forms but can be marketed in 1, 2, or 3 forms which the pharmaceutical company decided based on various background research results.
Composition is the list of ingredients which combinedly form a medicine. Both active ingredients and inactive ingredients form the composition. The active ingredient gives the desired therapeutic effect whereas the inactive ingredient helps in making the medicine stable.
Doses are various strengths of the medicine like 10mg, 20mg, 30mg and so on. Each medicine comes in various doses which is decided by the manufacturer, that is, pharmaceutical company. The dose is decided on the severity of the symptom or disease.
Ezevas destination | category:
Destination is defined as the organism to which the drug or medicine is targeted. For most of the drugs what we discuss, human is the drug destination.
Drug category can be defined as major classification of the drug. For example, an antihistaminic or an antipyretic or anti anginal or pain killer, anti-inflammatory or so.
Ezevas Anatomical Therapeutic Chemical codes:
A medicine is classified depending on the organ or system it acts [Anatomical], based on what result it gives on what disease, symptom [Therapeutical], based on chemical composition [Chemical]. It is called as ATC code. The code is based on Active ingredients of the medicine. A medicine can have different codes as sometimes it acts on different organs for different indications. Same way, different brands with same active ingredients and same indications can have same ATC code.
Ezevas pharmaceutical companies:
Pharmaceutical companies are drug manufacturing companies that help in complete development of the drug from the background research to formation, clinical trials, release of the drug into the market and marketing of the drug.
Researchers are the persons who are responsible for the scientific research and is responsible for all the background clinical trials that resulted in the development of the drug.
Frequently asked QuestionsCan i drive or operate heavy machine after consuming Ezevas?
Depending on the reaction of the Ezevas after taken, if you are feeling dizziness, drowsiness or any weakness as a reaction on your body, Then consider Ezevas not safe to drive or operate heavy machine after consumption. Meaning that, do not drive or operate heavy duty machines after taking the capsule if the capsule has a strange reaction on your body like dizziness, drowsiness. As prescribed by a pharmacist, it is dangerous to take alcohol while taking medicines as it exposed patients to drowsiness and health risk. Please take note of such effect most especially when taking Primosa capsule. It's advisable to consult your doctor on time for a proper recommendation and medical consultations.Is Ezevas addictive or habit forming?
Medicines are not designed with the mind of creating an addiction or abuse on the health of the users. Addictive Medicine is categorically called Controlled substances by the government. For instance, Schedule H or X in India and schedule II-V in the US are controlled substances.
Please consult the medicine instruction manual on how to use and ensure it is not a controlled substance.In conclusion, self medication is a killer to your health. Consult your doctor for a proper prescription, recommendation, and guidiance.
ReviewsDrugs.com conducted a study on Ezevas, and the result of the survey is set out below. It is noteworthy that the product of the survey is based on the perception and impressions of the visitors of the website as well as the views of Ezevas consumers. We, as a result of this, advice that you do not base your therapeutic or medical decisions on this result, but rather consult your certified medical experts for their recommendations.
The information was verified by Dr. Arunabha Ray, MD Pharmacology